The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
Open accessAbstract
Background: More and more studies have shown that circular RNAs (circRNAs) play a critical regulatory role in many cancers. However, the potential molecular mechanism of circRNAs in prostate cancer (PCa) remains largely unknown. Methods: Differentially expressed circRNAs were identified by RNA sequencing. The expression of hsa_circ_0003258 was evaluated using quantitative real-time PCR and RNA in situ hybridization. The impacts of hsa_circ_0003258 on the metastasis of PCa cells were investigated by a series of in vitro and in vivo assays. Lastly, the underlying mechanism of hsa_circ_0003258 was revealed by Western blot, biotin-labeled RNA pulldown, RNA immunoprecipitation, luciferase assays and rescue experiments. Results: Increased expression of hsa_circ_0003258 was found in PCa tissues and was associated with advanced TNM stage and ISUP grade. Overexpression of hsa_circ_0003258 promoted PCa cell migration by inducing epithelial mesenchymal transformation (EMT) in vitro as well as tumor metastasis in vivo, while knockdown of hsa_circ_0003258 exerts the opposite effect. Mechanistically, hsa_circ_0003258 could elevate the expression of Rho GTPase activating protein 5 (ARHGAP5) via sponging miR-653-5p. In addition, hsa_circ_0003258 physically binds to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) in the cytoplasm and enhanced HDAC4 mRNA stability, in which it activates ERK signalling pathway, then triggers EMT programming and finally accelerates the metastasis of PCa. Conclusions: Upregulation of hsa_circ_0003258 drives tumor progression through both hsa_circ_0003258/miR-653-5p/ARHGAP5 axis and hsa_circ_0003258/IGF2BP3 /HDAC4 axis. Hsa_circ_0003258 may act as a promising biomarker for metastasis of PCa and an attractive target for PCa intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788
Li, B., Zhu, L., Lu, C., Wang, C., Wang, H., Jin, H., Ma, X., Cheng, Z., Yu, C., Wang, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20527-z · Cited by 697
Self-citationWidespread and Functional RNA Circularization in Localized Prostate Cancer
Chen, S., Huang, V., Xu, X., Livingstone, J., Soares, F., Jeon, J., Zeng, Y., Hua, J. T., Petricca, J., Guo, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.025 · Cited by 544 · cited 2×
“Recently, more and more circRNAs have been noticed dysregulated in different kinds of malignancies, which participated in diversified physiological and pathological processes of tumors cells, including proliferation, cell cycle progression, and metastasis [9].”
BackgroundHDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target
Cheng, C., Yang, J., Li, S.-W., Huang, G., Li, C., Min, W.-P., & Sang, Y. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03417-0 · Cited by 49
Cited by
Lin, Z., Lv, D., Liao, X., Peng, R., Liu, H., Wu, T., Wu, K., Sun, Y., & Zhang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226962 · Cited by 39
Self-citationWang, Y., Liu, S., Chen, Y., Zhu, B., & Xing, Q. (2022) · World Journal of Oncology · doi:10.14740/wjon1446 · Cited by 17
“Moreover, inspired by the recent article (DOI: https://doi.org/10.1186/ s12943-021-01480-x) published in Molecular Cancer, Yu et al revealed the double mechanisms of hsa_circ_0003258 in prostate cancer (PCa) progression by a classical competing endogenous RNA (ceRNA) mechanism (hsa_circ_0003258/IGF2BP3/ HDAC4 axis) an…”
BackgroundInfluential
Metadata
- Authors
- Yu, Y.-Z., Lv, D.-J., Wang, C., Song, X.-L., Xie, T., Wang, T., Li, Z.-M., Guo, J.-D., Fu, D.-J., Li, K.-J., Wu, D.-L., Chan, F. L., Feng, N.-H., Chen, Z.-S., & Zhao, S.-C.
- Venue
- Molecular Cancer
- Published
- 2022-01-05
- Volume
- 21
- Issue
- 1
- Pages
- 12-12
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W4205514577
- Cited by
- 187
- References
- 6
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. https://app.cochat.ai/papers/10.1186/s12943-021-01480-x
- The paper
- Yu, Y.-Z., Lv, D.-J., Wang, C., Song, X.-L., Xie, T., Wang, T., Li, Z.-M., Guo, J.-D., Fu, D.-J., Li, K.-J., Wu, D.-L., Chan, F. L., Feng, N.-H., Chen, Z.-S., & Zhao, S.-C. (2022). Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Molecular Cancer. https://doi.org/10.1186/s12943-021-01480-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.